Business
Branded Legacy, Inc. Finalizes Transformative Acquisition of Bio Legacy Evaluative Group (f/k/a Menlo Health), Unlocking Explosive Growth Potential in Biotech and Drug Delivery
Branded Legacy, Inc. Finalizes Transformative Acquisition of Bio Legacy Evaluative Group (f/k/a Menlo Health), Unlocking Explosive Growth Potential in Biotech and Drug Delivery.
About this update from Branded Legacy Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Branded Legacy, Inc. Finalizes Transformative Acquisition of Bio Legacy Evaluative Group (f/k/a Menlo Health), Unlocking Explosive Growth Potential in Biotech and Drug Delivery\r\n \r\n \r\n\r\n\r\nBranded Legacy, Inc. Finalizes Transformative Acquisition of Bio Legacy Evaluative Group (f/k/a Menlo Health), Unlocking Explosive Growth Potential in Biotech and Drug Delivery\r\nAcquisition Poised to Drive Substantial Shareholder Value Through Innovative Technologies, Projected Multi-Million Revenues, and Strategic Leadership Alignment: Amin Janmohamed Steps Up as CEO and Dr. Kristian Thorlund as Chairman to Spearhead Long-Term Success\r\n\r\n\r\n\r\n\r\n\r\nVANCOUVER, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: BLEG), a dynamic diversified holdings company at the forefront of health and wellness innovation, is excited to announce the completion of its game-changing acquisition of Bio Legacy Evaluative Group, formerly Menlo Health (\"Bio Legacy\"). This strategic move, executed under an Acquisition Agreement dated July 28, 2025, propels Branded Legacy into the lucrative biotech and medical device arenas, targeting urgent global health challenges like the addiction epidemic and vaccine distribution inefficiencies. For shareholders, this acquisition represents a pivotal opportunity for enhanced value creation, with cutting-edge technologies set to capture significant market share in rapidly expanding sectors. Demonstrating a profound commitment to long-term growth and integration, Bio Legacy has rebranded from Menlo Health to Bio Legacy Evaluative Group, aligning seamlessly with Branded Legacy's vision. This rebranding underscores the team's dedication to building a unified powerhouse focused on sustainable expansion and enduring success within the public markets. Shareholders can rest assured: this is a team built for the long haul, laser-focused on delivering real, measurable growth, uplisting milestones, and substantial returns through disciplined execution and innovation. Key Transaction Highlights: Fueling Shareholder Prosperity The Acquisition Agreement delivers a shareholder-friendly structure designed to maximize upside potential: \r\n All-Stock Deal for Alignment: Branded Legacy acquired full ownership of Bio Legacy's equity, assets, IP, and operations in exchan...